The role of IL-17 in the pathogenesis of inflammatory and autoimmune disease is well known, particularly in autoimmune diseases characterized by high levels of type I IFN signaling, such as in systemic lupus erythematosus and dermatomyositis. This evidence concerns the gene IL17A and autoimmune disease.